Beit Jala Pharmaceutical Company

PLSE:BJP Stock Report

Market Cap: د.أ19.6m

Beit Jala Pharmaceutical Past Earnings Performance

Past criteria checks 2/6

Beit Jala Pharmaceutical has been growing earnings at an average annual rate of 12.8%, while the Pharmaceuticals industry saw earnings growing at 9.4% annually. Revenues have been growing at an average rate of 2.9% per year. Beit Jala Pharmaceutical's return on equity is 8.8%, and it has net margins of 14.1%.

Key information

12.8%

Earnings growth rate

12.8%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate2.9%
Return on equity8.8%
Net Margin14.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Beit Jala Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

PLSE:BJP Revenue, expenses and earnings (JOD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249110
30 Jun 249110
31 Mar 249210
31 Dec 2310210
30 Sep 2310210
30 Jun 2310210
31 Mar 2311220
31 Dec 2211220
30 Sep 2211220
30 Jun 2211220
31 Mar 2210120
31 Dec 2110120
30 Sep 219120
30 Jun 219120
31 Mar 219120
31 Dec 209120
30 Sep 209120
30 Jun 209120
31 Mar 209220
31 Dec 199110
30 Sep 198110
30 Jun 198110
31 Mar 197110
31 Dec 187110
30 Sep 188110
30 Jun 188110
31 Mar 188220
31 Dec 178220
30 Sep 178210
30 Jun 178210
31 Mar 178210
31 Dec 168210
30 Sep 168210
30 Jun 168210
31 Mar 168110
31 Dec 158210
30 Sep 157110
30 Jun 156110
31 Mar 157110
31 Dec 146110
30 Sep 146110
30 Jun 146110
31 Mar 146110
31 Dec 136110

Quality Earnings: BJP has high quality earnings.

Growing Profit Margin: BJP's current net profit margins (14.1%) are lower than last year (19.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BJP's earnings have grown by 12.8% per year over the past 5 years.

Accelerating Growth: BJP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BJP had negative earnings growth (-35.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (7.5%).


Return on Equity

High ROE: BJP's Return on Equity (8.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies